Diagnostic Testing & Technology Report

As Clinical Data (Newton, Mass.) sharpens its focus on developing targeted drugs for conditions such as depression, the biotechnology company has achieved significant growth in its pharmacogenomic testing division, PGxHealth. On June 15, Clinical Data reported fiscal 2009 revenues of $10.4 million, an increase of 104 percent over fiscal 2008 revenues of $5.1 million. PGxHealth test revenues for the fiscal year increased 116 percent, jumping from $4.6 million in fiscal 2008 to $9.9 million.